News & Updates

Nonaspirin NSAIDs help prevent postcolonoscopy CRC

24 Apr 2020

Use of nonsteroidal anti‐inflammatory drugs (NSAIDs), except aspirin, is associated with a lower risk of colorectal cancer (CRC) after a negative baseline colonoscopy, a recent study reports.

Nonaspirin NSAIDs help prevent postcolonoscopy CRC

24 Apr 2020

$Carfilzomib once-a-week effective for relapsed, refractory multiple myeloma$

Carfilzomib once-a-week effective for relapsed, refractory multiple myeloma

23 Apr 2020

Once-weekly carfilzomib appears to be optimally beneficial for patients with relapsed and refractory multiple myeloma (RRMM) regardless of baseline disease characteristics, a recent study has shown.

Carfilzomib once-a-week effective for relapsed, refractory multiple myeloma

23 Apr 2020

Apixaban on par with dalteparin in reducing VTE recurrence in cancer

22 Apr 2020 by

Patients with cancer who develop venous thromboembolism (VTE) could reduce their risk of VTE recurrence with the direct oral anticoagulant (DOAC) apixaban, which demonstrated noninferiority to subcutaneous dalteparin in the Caravaggio* trial.

Apixaban on par with dalteparin in reducing VTE recurrence in cancer

22 Apr 2020

Lung cancer death rates drop with CT screening

22 Apr 2020 by

Volume-based, low-dose computed tomography (CT) screening reduced lung cancer mortality rates in former and current smokers, the Dutch-Belgian NELSON* trial has shown.

Lung cancer death rates drop with CT screening

22 Apr 2020

PSMA PET-CT superior to CT plus bone scan in high-risk prostate cancer

21 Apr 2020 by

Prostate-specific membrane antigen (PSMA) PET-CT offers superior accuracy in identifying pelvic nodal or distant-metastatic disease in men with high-risk prostate cancer and may be a suitable replacement for conventional imaging with CT combined with bone scan, according to results of the proPSMA study.

PSMA PET-CT superior to CT plus bone scan in high-risk prostate cancer

21 Apr 2020

Pembrolizumab improves pCR in early triple-negative breast cancer

21 Apr 2020 by

The addition of the anti-PD-1* monoclonal antibody pembrolizumab to platinum-based neoadjuvant chemotherapy (CT) led to a significant increase in the proportion of women with early triple-negative breast cancer (TNBC) who had a pathological complete response (pCR), the phase III KEYNOTE-522 trial has shown.

Pembrolizumab improves pCR in early triple-negative breast cancer

21 Apr 2020

Photodynamic therapy plus aminolevulinic acid may improve cutaneous SCCis

20 Apr 2020

Treatment with photodynamic therapy (PDT) plus aminolevulinic acid (ALA) appears to be effective for some cases of cutaneous squamous cell carcinoma in situ (SCCis), suggests a recent study. In addition, anatomic location, tumour diameter and ALA incubation time contribute to the effectiveness of the combined therapy.

Photodynamic therapy plus aminolevulinic acid may improve cutaneous SCCis

20 Apr 2020

Hippocampal avoidance in WBRT better preserves cognitive function without compromising survival

20 Apr 2020 by

Hippocampal avoidance during whole-brain radiotherapy (HA-WBRT), together with memantine, better preserves cognitive function vs WBRT plus memantine in patients with brain metastases, without compromising survival, a multi-institutional phase III trial has shown.

Hippocampal avoidance in WBRT better preserves cognitive function without compromising survival

20 Apr 2020

Percutaneous endoscopic gastrostomy does not affect quality of life in HNC patients

18 Apr 2020

Prophylactic insertion of percutaneous endoscopic gastrostomy (PEG) tubes does not improve quality of life in patients with head and neck cancer (HNC), a recent study has shown.

Percutaneous endoscopic gastrostomy does not affect quality of life in HNC patients

18 Apr 2020

Selumetinib benefits children with inoperable plexiform neurofibromas

17 Apr 2020 by

Treatment with selumetinib, an oral selective MEK inhibitor, leads to sustained reduction in neurofibroma volume and clinical benefit in children with neurofibromatosis type 1–inoperable plexiform neurofibromas, according to a recent study.

Selumetinib benefits children with inoperable plexiform neurofibromas

17 Apr 2020

News & Updates

Filter by Specialty:

Specialty:

Nonaspirin NSAIDs help prevent postcolonoscopy CRC

Nonaspirin NSAIDs help prevent postcolonoscopy CRC

Carfilzomib once-a-week effective for relapsed, refractory multiple myeloma

Carfilzomib once-a-week effective for relapsed, refractory multiple myeloma

Apixaban on par with dalteparin in reducing VTE recurrence in cancer

Apixaban on par with dalteparin in reducing VTE recurrence in cancer

Lung cancer death rates drop with CT screening

Lung cancer death rates drop with CT screening

PSMA PET-CT superior to CT plus bone scan in high-risk prostate cancer

PSMA PET-CT superior to CT plus bone scan in high-risk prostate cancer

Pembrolizumab improves pCR in early triple-negative breast cancer

Pembrolizumab improves pCR in early triple-negative breast cancer

Photodynamic therapy plus aminolevulinic acid may improve cutaneous SCCis

Photodynamic therapy plus aminolevulinic acid may improve cutaneous SCCis

Hippocampal avoidance in WBRT better preserves cognitive function without compromising survival

Hippocampal avoidance in WBRT better preserves cognitive function without compromising survival

Percutaneous endoscopic gastrostomy does not affect quality of life in HNC patients

Percutaneous endoscopic gastrostomy does not affect quality of life in HNC patients

Selumetinib benefits children with inoperable plexiform neurofibromas

Selumetinib benefits children with inoperable plexiform neurofibromas